Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Hematology

Stem Cell Transplant Clinical Trials

A listing of Stem Cell Transplant medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Arizona

Scottsdale Arizona 85259

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

California

La Jolla California

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Georgia

Memorial University Medical Center
Savannah Georgia 31404

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

View More ▼

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Illinois

Chicago Illinois 60612

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Maine

Brewer Maine 04412

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Maryland

Baltimore Maryland 21201

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Massachusetts

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Hyannis Massachusetts 02601

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Newton Massachusetts

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Mississippi

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

New Hampshire

Concord New Hampshire

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Hooksett New Hampshire

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Laconia New Hampshire

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

New York

Brooklyn New York

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Buffalo New York 14263

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

New York New York 10029

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

New York New York 10029

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

New York New York 10021

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

North Carolina

Chapel Hill North Carolina 27599

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Winston-Salem North Carolina 27103

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Winston-Salem North Carolina 27157

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Ohio

Columbus Ohio 43210

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Oregon

Portland Oregon

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Pennsylvania

Pittsburgh Pennsylvania 15232

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Texas

Dallas Texas 75390

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Houston Texas 77030

A clinical research study of Cytotoxic T-Lymphocytes (CTL) for the treatment of Blood And Marrow Transplantation or Infection

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Washington

Seattle Washington 98109

Patients are needed to participate in a clinical research study evaluating Lenalidomide, Bortezomib, Dexamethasone and Autologous Stem Cell Transplant for the treatment of Multiple Myeloma

Canada

Toronto M5G 2M9

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis